KCNA10 (Kinesin Family Member 28 Pseudogene is unrelated — gene symbol collision resolved) is a potassium voltage-gated channel gene located at chromosome 1p21.3 (NCBI Gene ID: 3744, UniProt: Q9NSC2, OMIM: 602224). KCNA10 encodes the Kv1.6 potassium channel subunit, a member of the KCNA subfamily of voltage-gated potassium channels. Unlike other Kv1 family members, KCNA10 exhibits distinctive biophysical properties including activation at relatively negative membrane potentials and slow inactivation kinetics. This channel plays critical roles in renal potassium secretion, inner ear function, and modulates neuronal excitability. While predominantly expressed in non-neuronal tissues, KCNA10's role in calcium signaling, oxidative stress responses, and neuroimmune interactions makes it relevant to understanding neurodegenerative disease mechanisms.
¶ Gene Structure and Protein Architecture
The human KCNA10 gene spans approximately 18 kb on chromosome 1p21.3 and consists of 2 coding exons. The gene encodes a 499 amino acid protein with a predicted molecular weight of approximately 56 kDa. KCNA10 is adjacent to KCNA3 in a head-to-tail cluster, suggesting common evolutionary origin.
The Kv1.6 channel subunit shares the canonical architecture of Kv1 family channels:
- S1-S4 voltage sensor domain: S4 contains positively charged residues that sense membrane potential changes
- S5-S6 pore domain (P loop): Forms the ion selectivity filter with signature TXVGYG motif
- Tetramerization domain (T1): N-terminal domain mediating channel assembly
- C-terminal regulatory domain: Contains binding sites for auxiliary subunits and post-translational modification sites
| Property |
KCNA1 (Kv1.1) |
KCNA2 (Kv1.2) |
KCNA4 (Kv1.4) |
KCNA10 (Kv1.6) |
| Activation V½ |
~-40 mV |
~-30 mV |
~-30 mV |
~-50 mV |
| Inactivation |
Slow N-type |
Very slow |
Fast N-type |
Very slow |
| TEA sensitivity |
High |
High |
Moderate |
Moderate |
| Tissue distribution |
Neurons, glia |
Brain, pancreas |
Brain, muscle |
Kidney, inner ear |
¶ Molecular Function and Channel Properties
KCNA10 channels exhibit unique electrophysiological properties:
Activation:
- Opens at more negative voltages compared to other Kv1 members (activation threshold ~-60 mV)
- Steep voltage dependence (e-fold per 6-7 mV)
- Rapid activation kinetics with time constant ~5-10 ms at +20 mV
Inactivation:
- Extremely slow inactivation (seconds to minutes)
- Lacks the canonical N-terminal inactivation domain found in Kv1.4
- Results in sustained potassium currents during prolonged depolarization
Ion selectivity:
- Highly selective for potassium over sodium (>100:1 selectivity ratio)
- Blocked by tetraethylammonium (TEA, IC50 ~0.3 mM)
- Not blocked by dendrotoxin (distinguishes from Kv1.1, Kv1.2)
Pharmacology:
- TEA-sensitive
- 4-aminopyridine (4-AP) sensitive with moderate affinity
- Aflatoxin B2 (ATX-II) enhances channel activity
- No significant sensitivity to dendrotoxins
KCNA10 can form both homomeric and heteromeric channels:
- Homomeric KCNA10 channels: Functional channels with characteristic slow inactivation
- Heteromeric assembly with KCNA1, KCNA2, KCNA4: Creates channels with intermediate properties
- Auxiliary subunit interactions: Associates with KCNS2 (Kv9.2) and KCNAB1/KCNAB2 (Kvβ1/2) subunits
Beyond its role as an ion conductance pathway, KCNA10 modulates cellular signaling:
- Membrane potential stabilization: Maintains resting membrane potential near K+ equilibrium potential
- Calcium signaling modulation: Affects calcium entry through voltage-dependent channels
- Cell volume regulation: Coordinates with volume-regulated anion channels
- Apoptosis regulation: Potassium efflux through Kv channels influences apoptotic cascade
¶ Tissue Distribution and Expression
KCNA10 shows highly tissue-specific expression pattern:
Kidney:
- Highest expression in connecting tubule and cortical collecting duct
- Co-localizes with NCC (sodium-chloride cotransporter) and ENaC (epithelial sodium channel)
- Essential for renal potassium secretion under high-potassium dietary conditions
Inner ear:
- Expressed in cochlear and vestibular hair cells
- Regulates potassium homeostasis in endolymph
- Critical for auditory and vestibular function
Lower expression:
- Liver (hepatocytes)
- Lung (bronchial epithelium)
- Heart (cardiomyocytes — trace levels)
- Retina (retinal ganglion cells — minimal)
KCNA10 expression is dynamically regulated:
- Transcriptional: Aldosterone increases KCNA10 transcription in kidney
- Post-translational: Channel activity modulated by tyrosine phosphorylation
- Alternative splicing: Limited — most transcripts encode full-length protein
- Developmental: Expression increases postnatally in kidney
KCNA10 is a key component of the renal potassium secretion machinery:
In the connecting tubule and collecting duct:
- Apical ROMK (KCNJ1) channels: Primary pathway for K+ secretion into tubular lumen
- Basolateral K+ channels: Maintain intracellular K+ gradient
- KCNA10 contribution: Provides sustained K+ efflux during high-flow conditions
- High-K+ diet: Aldosterone + flow → KCNA10 upregulation
- Diuretic treatment: Loop diuretics increase distal flow → KCNA10 compensates
- Acid-base status: Alkalosis enhances KCNA10 activity
KCNA10 dysfunction leads to:
- Renal potassium wasting: Hypokalemia, especially under high-K+ load
- Salt-sensitive hypertension: Impaired pressure-natriuresis
- Bartter-like phenotype: When combined with ROMK dysfunction
The inner ear maintains unique ionic composition:
- Endolymph ( scala media): High K+ (150 mM), low Na+ — unique extracellular fluid
- Positive endocochlear potential: +80 mV relative to perilymph
- Generated by stria vascularis: K+ pumping into endolymph
In vestibular and cochlear hair cells:
- Apical membrane location: KCNA10 localizes to stereocilia (mechanosensitive hair bundles)
- Repolarization role: Returns membrane potential after depolarization
- Oscillatory properties: Contributes to receptor potentials and frequency tuning
¶ Hearing and Balance Function
KCNA10 mutations cause:
- Non-syndromic hearing loss: Variable severity, typically moderate
- Auditory neuropathy: Normal OAE but abnormal ABR
- Vestibular dysfunction: Impaired balance in some patients
While KCNA10 is not classically considered a neuronal channel, several mechanisms link it to neurodegeneration:
¶ Potassium Homeostasis and Neuronal Excitability
Potassium channel dysfunction broadly affects neurodegeneration:
- Axonal potassium buffering: Altered K+ dynamics in perivascular spaces
- Synaptic excitation: Indirect effects through shared signaling pathways
- Glial-neuronal coupling: Astrocyte K+ buffering affects neuronal survival
Kv1.6, including KCNA10, participates in oxidative stress signaling:
- ROS-activated channels: Certain reactive oxygen species potentiate KCNA10
- Apoptosis regulation: K+ efflux through Kv channels triggers apoptotic cascades
- Neuroprotection strategies: Kv channel modulators show neuroprotective potential
Emerging evidence links KCNA10 to neuroimmune interactions:
- Macrophage potassium channels: KCNA10 in immune cells affects cytokine production
- Microglial activation: K+ channel activity modulates microglial morphing
- Blood-brain barrier integrity: Perivascular cell K+ channels affect BBB function
Alzheimer's disease:
- Amyloid-beta directly affects Kv channel function
- KCNA10-like currents modulated by Aβ oligomers
- Tau pathology alters Kv channel trafficking to membranes
Parkinson's disease:
- Dopaminergic neurons rely on K+ channel activity for pacemaking
- Mitochondrial dysfunction affects Kv channel regulation
- Oxidative stress modulates channel properties
Kv1.6 represents a potential therapeutic target:
Agonists (channel openers):
- Retigabine (Ezogabine) — approved for epilepsy, activates Kv7 channels, not Kv1.6
- Flupirtine — broad Kv channel activator with neuroprotective properties
- BMS-204352 — Kv1.6 opener, explored for stroke
Antagonists (channel blockers):
- 4-aminopyridine (4-AP) — broad Kv channel blocker, used for multiple sclerosis
- TEA derivatives — selective for some Kv1 channels
KCNA10 modulators could treat:
- Hypokalemia disorders: Enhance or reduce K+ secretion
- Hypertension: Modulate renal salt handling
- Bartter/Gitelman syndromes: Compensate for upstream defects
- Aminoglycoside otoprotection: Understanding KCNA10 function informs aminoglycoside toxicity mechanisms
- Age-related hearing loss: KCNA10 expression declines with age
Kcna10 null mice:
- Show mild hypokalemia under high-K+ diet
- No significant hearing deficit (suggesting redundancy with other Kv channels)
- Increased susceptibility to K+ challenge
- Morpholino knockdowns cause inner ear defects
- Vestibular dysfunction phenotype
¶ Genetic Variants and Disease Associations
- Missense variants in S4-S5 linker: Associated with hearing loss
- Truncating variants: Cause autosomal recessive sensorineural hearing loss (DFNA49)
- Variants in pore domain: Altered TEA sensitivity and channel properties
- rs2299497: Common variant associated with serum potassium levels
- rs3756783: Linked to blood pressure in GWAS studies
Kcna10 Gene Potassium Voltage Gated Channel Subfamily A Member 10 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| KCNA10 |
|---|
| Full Name | Potassium Voltage-Gated Channel Subfamily A Member 10 |
| Category | Gene |
| Path | /genes/kcna10 |
| Chromosome | 1p21.3 |
| Protein | Potassium voltage-gated channel subfamily A member 10 |
KCNA10 (Potassium Voltage-Gated Channel Subfamily A Member 10) encodes a voltage-gated potassium (Kv) channel subunit. Unlike other Kv1 family members, KCNA10 has unique properties including a slower inactivation rate and activation at more negative membrane potentials. This gene is located on chromosome 1p21.3.
KCNA10 forms functional potassium channels with distinct biophysical properties:
- Renal Potassium Secretion: KCNA10 plays a crucial role in potassium secretion in renal tubular cells, particularly in the connecting tubule and cortical collecting duct
- Inner Ear Function: Expressed in hair cells of the inner ear, KCNA10 contributes to potassium homeostasis essential for auditory transduction
- Vascular Tone: Some studies suggest a role in regulating vascular smooth muscle tone
- Unique Gating Properties: KCNA10 activates at more negative voltages compared to other Kv1 channels, allowing it to open at resting membrane potentials
KCNA10 mutations and dysregulation are associated with:
- Renal Disorders:
- Hypokalemic periodic paralysis (secondary)
- Renal potassium wasting
- Bartter syndrome-like phenotypes
- Hearing Loss:
- Nonsyndromic hearing loss
- Auditory neuropathy spectrum disorder
- Cardiovascular Effects: Potential implications in blood pressure regulation
KCNA10 shows highly tissue-specific expression:
- Kidney: Highest expression in connecting tubule and cortical collecting duct
- Inner Ear: Hair cells of the cochlea and vestibular system
- Liver: Lower expression
- Lung: Minor expression
- Heart: Trace expression
KCNA10 has distinctive properties:
- Activation: Fast activation at relatively negative voltages (-40 to -30 mV)
- Inactivation: Very slow inactivation, resulting in sustained currents
- Pharmacology: Sensitive to tetraethylammonium (TEA)
- Co-assembly: Can form homomers and heteromers with other Kv1 subunits
KCNA10 interacts with:
- KCNA1 (Kv1.1)
- KCNA2 (Kv1.2)
- KCNA4 (Kv1.4)
- KCNB1 (Kvβ1) auxiliary subunits
KCNA10 represents a potential therapeutic target for:
- Hypertension management through renal potassium channel modulation
- Hearing loss prevention/ treatment
- Disorders of potassium homeostasis
- KCNA10 in renal potassium secretion (2018)
- KCNA10 expression in the inner ear (2019)
- Voltage-gated potassium channels in kidney disease (2020)
The study of Kcna10 Gene Potassium Voltage Gated Channel Subfamily A Member 10 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.